Corporate · Healthcare

Healthcare general counsel search for hospital systems, payers and health services

The officer owns HIPAA, physician arrangements, the contract that pays for care, and the affiliation. A drug-and-device brief is a different search.

Brief a search How we run a search
01 Direct answer

A healthcare GC is hired to own the care-delivery file, not a generic commercial book and not an FDA calendar.

Hospital systems, payers and health-services companies ask for this officer. The cross-industry search is a different page. The clock is the same GC clock.

A healthcare general counsel is the officer a board names when a physician contract, a health-plan agreement, a breach or an affiliation can move the enterprise. The seat shows up at a health system that has outgrown outside counsel on medical-staff and Stark questions, at a plan whose Medicare Advantage book is now the business, or at a physician platform, surgery center or behavioral-health company that has become a multi-state operator. It is not a scaled-down version of a diversified-company GC. It is also not the officer who lives on an IND, a 510(k) or an Orange Book date.

Reporting line, fee, off-limits, the 24-day shortlist and the 11-week median are set out on general counsel search. What changes for hospitals, payers and health services is who qualifies: HIPAA, the Stark Law, the Anti-Kickback Statute, payer contracts and M&A. A company that makes a drug, a biologic or a device starts at life sciences general counsel search. A company hiring its first lawyer, in healthcare or elsewhere, starts at first general counsel search. A company replacing a sitting officer starts at general counsel succession. The sector map is healthcare and life sciences.

Sartori & Partners has completed 230+ in-house and corporate placements since 2017, of which 38 were General Counsel or Chief Legal Officer. Hospital, payer and health-services GC mandates sit inside that 38. There is not a separate healthcare count, and there is not a separate healthcare clock. The shortlist is 24 days. The median accepted offer is 11 weeks, range 8-16 weeks. Offer acceptance on corporate mandates is 96 percent. Retained corporate mandates complete at 92 percent. Twelve-month retention of placed in-house leaders is 97 percent; 24-month retention is 91 percent. The replacement term on a retained GC search is 12 months.

The published file in this orbit is a device company, not a hospital. A NASDAQ-listed medtech in Boston ran a blind succession while the sitting general counsel was still in post: a shortlist of four on day 24, an accepted offer in week 11, and the 12-month retention checkpoint held (the Boston medtech succession). A health system that also owns a plan and a physician group is still this search. A device subsidiary does not turn the whole brief into a life sciences search.

Seat
General counsel or CLO for a hospital system, payer or health-services company, scored on HIPAA, Stark, the Anti-Kickback Statute, payer contracts and M&A.
Clock
Shortlist in 24 days; median accepted offer in 11 weeks; range 8-16 weeks (n=38 GC/CLO, 2017-2026).
Proof
38 GC/CLO of 230+ in-house placements. No separate healthcare count. NASDAQ medtech, Boston: four names on day 24, accepted offer week 11.
Terms
Retained only. Fee 25-30% of total first-year compensation, 30% of the fee as retainer, 12-month replacement.
When not
A drug, biologic or device GC search, a pure Stark-counsel search, or a CCO seat the board wants independent of legal.
Research
Figures on this page are Sartori & Partners track record unless a source is named.
02 The four files

HIPAA, Stark and the Anti-Kickback Statute, payer contracts, M&A. A brief that names only one of them is incomplete.

Each file changes who is actually qualified. A commercial GC from outside healthcare fails a different one of the four.

I

HIPAA

Privacy, Security and Breach Notification Rules, 45 C.F.R. Parts 160 and 164. The first cut is whether the company is a covered entity, a business associate, or both. HHS published a proposed Security Rule update on 6 January 2025.

II

Stark and the Anti-Kickback Statute

Physician Self-Referral Law, 42 U.S.C. § 1395nn, is strict liability unless an exception fits. The Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b), is a criminal prohibition on remuneration for federal-program referrals. The civil path for both is usually the False Claims Act.

III

Payer contracts

The agreement that pays the hospital, the group or the plan. In 2026, 35.2 million people, 55 percent of 64.2 million eligible Medicare beneficiaries, were in Medicare Advantage. MedPAC reported Medicare paid Advantage plans 14 percent more per person in 2026, about $76 billion.

IV

M&A and affiliation

Kaufman Hall counted 46 announced hospital and health-system transactions in 2025, $18.5 billion of transacted revenue, and a record 43.5 percent involving a financially distressed party. The GC owns the affiliation, the medical staff and the change-of-control in the payer contracts.

HIPAA is the file that separates a health-system GC from a commercial GC who has "done privacy" as a policy. A hospital or health plan is ordinarily a covered entity. A revenue-cycle company, a telehealth platform that does not bill as a provider, or a software vendor sitting on electronic protected health information is often a business associate, sometimes both. The officer has to know which hat the company is wearing before the breach clock starts. The Privacy, Security and Breach Notification Rules live in 45 C.F.R. Parts 160 and 164. On 6 January 2025, HHS published a proposed rule to strengthen the HIPAA Security Rule (Federal Register, document 2024-30983). A 2026 brief asks whether the candidate has run the Security Rule now in force and has read that proposal. The 6 January 2025 notice is not itself a final rule.

The second file is physician money. The Physician Self-Referral Law, 42 U.S.C. § 1395nn, restricts a physician from referring Medicare patients for designated health services to an entity with which the physician, or an immediate family member, has a financial relationship, unless an exception applies. It is strict liability. Employment, leases, call coverage, medical directorships and value-based arrangements are legal only when an exception actually fits the paper. The Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b), is the criminal statute: knowingly and willfully offering, paying, soliciting or receiving remuneration to induce referrals of business payable by a federal health care program. Intent is the difference. A counsel who treats the two statutes as one policy memo will sign arrangements that one of them prohibits.

Those statutes reach the board through the False Claims Act. The Department of Justice announced on 16 January 2026 that settlements and judgments under the Act exceeded $6.8 billion in the fiscal year ending 30 September 2025, the highest annual total in the history of the Act, and that over $5.7 billion related to the health care industry. Whistleblowers filed 1,297 qui tam suits in that year, a single-year record. The Department named three areas in which it had continued and expanded its work: managed care, prescription drugs, and medically unnecessary care. The $5.7 billion is federal loss only. State Medicaid recoveries sit on top of it. A hospital GC and a payer GC both live inside that number. They do not live in it the same way. The hospital file is physician arrangements, medical necessity and cost reporting. The payer file is risk adjustment, the bid and the provider contract.

Payer contracts are the third file, and in 2026 they are a Medicare Advantage file for a large share of the market. KFF's analysis of CMS enrollment files, published 5 June 2026 and updated 1 July 2026, found 35.2 million people enrolled in Medicare Advantage, 55 percent of 64.2 million Medicare beneficiaries with both Part A and Part B. Enrollment grew by about 1.1 million people, 3 percent, from 2025. UnitedHealth Group and Humana together accounted for 46 percent of Medicare Advantage enrollment (UnitedHealth 9.3 million, 26 percent; Humana 7 million, 20 percent). The same KFF brief, citing the Medicare Payment Advisory Commission's March 2026 Report to Congress, reported that Medicare payments to Advantage plans in 2026 were 14 percent higher per person than spending for similar beneficiaries in traditional Medicare, about $76 billion in additional federal spending. A GC who has only negotiated a commercial PPO contract has not owned that book.

The paper itself is a participation agreement, a risk deal, a delegation schedule, or a health-system contract with a plan. It allocates prior authorization, medical necessity, prompt pay, the No Surprises Act dispute path, data rights, and what happens to the contract if either party is sold. On the plan side it also includes the bid, the state insurance filing and the risk-adjustment audit. On 30 September 2026 the Department of Justice announced that Independence Blue Cross had agreed to pay $22.5 million to resolve allegations that it retained Medicare Advantage overpayments by failing to withdraw inaccurate diagnosis codes. The same announcement said the government pays private insurers over $530 billion a year for Medicare Advantage, and it stated that the claims resolved were allegations only. One resolution is not a market total. It is the exposure a payer general counsel is hired to own. A provider GC who cannot read the plan's contract will concede economics the CFO thinks legal has already approved.

M&A is the fourth file, and in hospitals it is often an affiliation of a distressed seller rather than a cash auction between two healthy systems. Kaufman Hall's year-end review, published 15 January 2026, counted 46 announced hospital and health-system transactions in 2025. Total transacted revenue was $18.5 billion, of which $9.8 billion came in the fourth quarter. The share of transactions involving a financially distressed party reached 43.5 percent, a record in that series. For-profit organizations were the seller in 11 of the 46 and the acquirer in one. The fourth quarter had 17 announced transactions, including four in which the smaller party's annual revenue exceeded $1 billion. The officer on that deal owns antitrust and state review, bond covenants, medical-staff bylaws, pension and benefit liabilities, the religious or governmental character of the seller where that exists, and every payer contract with a change-of-control clause. A capital-markets GC who has closed a software acquisition has not done this work.

Week 1 names which of the four files the officer owns and which stay with a deputy, a compliance officer or outside counsel. The search that stalls asks for one person who has been the HIPAA security officer, the Stark specialist, the Medicare Advantage lead and the deal lead. That person is a department. Revenue under $50 million usually means one lawyer. Revenue of $50 million to $250 million usually means two to four. A system at $1 billion to $5 billion is briefed at 12 to 18 lawyers, and a system above $5 billion at 25 to 60. Those are the bands we use for any company at that revenue. They are not a hospital census.

03 The pool

Sitting counsel in hospitals, plans and health services. Not a posted job, and not a law-firm partner by default.

Who we map

Deputy and associate general counsel at regional and national health systems who have signed physician employment, call coverage or a lease and have lived a Stark review through a fair-market-value opinion. General counsel and deputies at health plans and managed-care companies who have negotiated a health-system participation agreement and sat with the Medicare Advantage bid. General counsel and deputies at multi-state physician groups, surgery-center platforms, behavioral-health operators and post-acute companies. A small number of sitting GCs, approached only when the scorecard is a successor seat and the process is blind.

Who we do not start with

A law-firm healthcare partner, unless the company is explicit that it wants a first-time in-house officer and will accept the ramp. An FDA product counsel, who belongs on a life sciences search. A compliance officer who has never run a legal department, when the title on the requisition is general counsel. Advertised candidates. The market map we work from is 1,480,000+ lawyers. The healthcare GC list inside it is the people who have already held one of the four files at a comparable employer.

Sub-sectors, with the hiring profile that actually differs: hospitals and health systems, managed care and payers, and digital health. Drug, biologic and device companies: life sciences general counsel search.

04 The profile

Arrangement-literate. Contract-literate. Board-ready. In that order.

A healthcare GC who has only run a mature listed department will try to hire a team the system cannot pay. A GC who has only done commercial contracts will freeze when the whistleblower letter arrives.

A

Arrangement-literate

Has held the pen on a physician employment agreement, a medical directorship or a lease, and can say which Stark exception was doing the work. Can tell the Anti-Kickback Statute from Stark without a memorandum. Does not need outside counsel in the room to answer the first question from the audit chair.

B

Contract-literate

Has negotiated the agreement that pays for care: a plan-provider contract, a risk deal, or the Medicare Advantage machinery around it. Knows which clauses move in a renewal and which a change of control will reopen. Can read a bid and a risk-adjustment finding, not only a services schedule.

C

Board-ready

Reports to the chief executive in the design we lock, consistent with the 84 percent of chief legal officers who report to the CEO in the ACC 2026 survey. Can explain a reserve and an affiliation in the system's numbers. Can tell the board when the compliance seat should not report to legal.

Team size is the constraint on the profile. The bands we use in briefing, for any industry: under $50 million of revenue, or Series B to C, one lawyer; $50 million to $250 million, two to four; $1 billion to $5 billion, 12 to 18; above $5 billion, 25 to 60. A candidate whose last team was larger than the company can staff will spend the first year hiring. We treat that as a mismatch. Where the company needs a second chair rather than the officer, the search is a deputy general counsel mandate: 47 deputy and Head of Legal placements since 2017, shortlist in 21 days, median accepted offer in 10 weeks. Where the company needs a Stark or reimbursement counsel and already has a GC, that is a specialist search on an 18-day shortlist and an 8-week median to offer, inside 96 senior and specialist placements, not a healthcare GC search.

05 Mandate scorecard

Five lines we lock in week 1. Outreach does not start without them.

  1. 01
    Which of the four files is the job. HIPAA, physician arrangements, payer contracts, or a live affiliation. If a signing, a CMS response or a breach notification falls inside the 11-week search, we staff interim legal talent in parallel. Interim starts on a 7-day median across 60+ engagements, counted separately from the 230+ permanent placements. It is not a substitute for the retained search.
  2. 02
    Covered entity, business associate, or plan. A health system, a Medicare Advantage organization and a revenue-cycle vendor do not share a HIPAA scorecard. The employer type is locked before the first call.
  3. 03
    Where compliance sits. Inside this seat, or a peer chief compliance officer. ACC 2026: 64 percent of chief legal officers have majority oversight of compliance, and 84 percent report to the chief executive. That is the global pattern, from 1,049 chief legal officers across 20 industries and 43 countries, fielded 10 September to 7 November 2025. It is not a reason to ignore an independence requirement. We will not run both searches under one job description.
  4. 04
    The live contract or the live deal. Which payer agreement is in renewal, which physician arrangement is unsigned, which affiliation has a date. A company with no transaction in sight should not screen for a deal GC and then be surprised by the Stark gap.
  5. 05
    Cash, reporting line, off-limits. CEO reporting unless the board has a written reason otherwise. Cash from the bands below. A nonprofit system does not get a listed-company equity story. We never recruit from a client's legal department for 24 months after a mandate, and we never approach lawyers we placed for as long as they stay. Both go in the letter with the fee.
06 How the search runs

The GC clock is 24 days to shortlist. The median accepted offer is week 11.

  1. Week 1 Mandate Blueprint

    Scorecard, HIPAA posture, physician-arrangement file, payer contracts, any live affiliation, compliance line, cash, conflicts, off-limits. Written. No calls before this exists.

  2. Weeks 1-2 Map the sector

    Sitting GCs and deputies at health systems, plans or health-services companies of a comparable type. A hospital search does not open with payer deputies, and the reverse.

  3. Weeks 2-4 Private outreach

    Blind both ways until mutual interest. A succession does not tell the market the sitting GC is leaving. NDA on request.

  4. Day 24 Shortlist dossiers

    Assessment dossiers. Boston medtech: four names, each already able to sit with the board. The same standard on a hospital, payer or health-services GC.

  5. Weeks 5-11 Interviews and offer

    CEO, chair, often the audit chair. Range 8-16 weeks because those calendars slip. Median accepted offer week 11, n=38.

  6. After start Close and 90-day checks

    Onboarding and 90-day check-ins. 97 percent of placed in-house leaders still in post at 12 months; 91 percent at 24 months.

Process detail is on how we run a search. The cross-industry parent is general counsel search. The written method is how to run a general counsel search. After close, integration counsel is a post-merger legal integration brief, not a second GC search.

07 What to budget

Stage bands. Not a hospital price list, and not the large-cap total.

Cash figures are Sartori & Partners 2026 banding from closed GC mandates. The healthcare seat uses the band that matches the company's stage and whether it can grant equity. The large-cap total is proxy context only.

General counsel cash bands used for healthcare seats, 2026. Base and bonus. Sartori & Partners closed-search banding unless noted.
SeatBase (USD)BonusSource
Series B-C / first GC, including a first health-services GC$240,000-$340,00020-40%Sartori closed searches, 2017-2026
Growth-stage / pre-IPO healthcare GC$300,000-$420,00030-60%Sartori closed searches, 2017-2026
PE-backed healthcare portfolio GC$280,000-$420,00025-50%Sartori closed searches, 2017-2026
Mid-cap listed payer or health-services GC$450,000-$650,00060-100%Sartori closed searches, 2017-2026
Large-cap listed GC (context only)$650,000-$1.1 million baseMedian total compensation $4.76m, not baseSartori & Partners analysis of SEC proxy filings, 2026 proxy season

Do not bid a nonprofit health-system GC off the $4.76m large-cap total. Retained fee is 25-30 percent of total first-year compensation, with a retainer of 30 percent of the fee paid at engagement.

Source: Sartori & Partners closed-search banding, 2017-2026; Sartori & Partners analysis of SEC proxy filings, 2026 proxy season.

Pay by stage: general counsel salary 2026. Who listed companies appoint, and from where: General Counsel Appointments Tracker. What the largest US-listed companies pay the seat: General Counsel Pay. A nonprofit system uses the cash band and does not inherit the equity line of a listed payer.

08 Proof

38 GC and CLO seats. The published file in this orbit is a NASDAQ-listed medtech succession in Boston.

38
GC and CLO placements.Of 230+ in-house placements since 2017. Healthcare sits inside this count.
Sartori & Partners
24 days
To a GC/CLO shortlist.Median accepted offer in 11 weeks. Range 8-16.
Sartori & Partners
96%
Offer acceptance.Corporate retained mandates. 92% of retained mandates complete.
Sartori & Partners
12 mo
Replacement term on retained GC searches.97% of placed in-house leaders still in post at 12 months.
Sartori & Partners

Case

GC succession, NASDAQ-listed medtech, Boston

Medtech · NASDAQ-listed · Boston

General counsel successionRead the case study

Situation
The sitting general counsel was still in post. The board could not signal a vacancy. The successor had to speak to the board. The employer is a device company, which is why a hospital or payer search is not a copy of this file.
Approach
Blind retained search. Mandate Blueprint and the 12-month replacement term in the letter before anyone was called. Mapped listed medtech general counsel and deputies.
Outcome
Shortlist of four. Accepted offer in week 11. The 12-month retention checkpoint held. One of 38 GC and CLO searches.

Timeline: Shortlist day 24; accepted offer week 11.

Client reference

What the buyer said

The shortlist arrived in just over three weeks and every name could already sit with our board. The person we hired is still in post two years later.

General Counsel NASDAQ-listed medtech · Boston

The quote is from that medtech succession. We do not attach it to a hospital system or a payer. Retained corporate mandates complete at 92 percent. Twelve-month retention of placed in-house leaders is 97 percent; 24-month retention is 91 percent. A brief that asks for four officers in one person is the brief we stop in week 1.

Healthcare general counsel search — questions

What does a healthcare general counsel recruiter search for?

A general counsel or chief legal officer for a hospital system, a payer or a health-services company, scored on HIPAA, the Stark Law, the Anti-Kickback Statute, payer contracts and M&A. The cross-industry method sits on general counsel search. A drug, biologic or device company is a life sciences general counsel search. Sector map: healthcare and life sciences.

How is a hospital or payer GC search different from a general corporate GC search?

The disqualifiers are different. A corporate GC who has never owned a physician financial relationship, a health-plan contract or a HIPAA security program will not survive the first board meeting after a whistleblower or a breach. In fiscal 2025, False Claims Act settlements and judgments exceeded $6.8 billion, and over $5.7 billion of that related to the health care industry, with managed care named as one of three major areas (Department of Justice, 16 January 2026). A software or industrial seat stays on general counsel search.

Should the healthcare general counsel also be the chief compliance officer?

Only when the board has decided the seats are combined and the person has run a legal department, not only a compliance program. Association of Corporate Counsel data from the 2026 Chief Legal Officers Survey puts majority oversight of compliance at 64 percent of CLOs. A corporate integrity agreement commonly requires a compliance officer with a reporting line to the board that does not run only through the general counsel. That independent officer is a chief compliance officer search, inside 41 compliance-leadership placements since 2017. We will not run both searches under one job description.

How long does a healthcare general counsel search take?

On the 38 GC and CLO searches since 2017, the shortlist arrived in 24 days and the median accepted offer in 11 weeks. The range is 8-16 weeks. Hospital, payer and health-services seats run on that clock. They do not get a separate one, and we do not publish a separate healthcare count. A NASDAQ-listed medtech succession in Boston produced a shortlist of four on day 24 and an accepted offer in week 11, and the 12-month retention checkpoint held. Read the Boston medtech succession and how we run a search.

What should we budget for a healthcare general counsel?

Use the stage band. We do not publish a hospital or payer tariff. Series B to C first GC cash is $240,000 to $340,000 base plus a 20 to 40 percent bonus. Growth-stage and pre-IPO seats run $300,000 to $420,000 base with a 30 to 60 percent bonus. PE-backed portfolio GC cash is $280,000 to $420,000 base with a 25 to 50 percent bonus. Mid-cap listed GC cash is $450,000 to $650,000 base with a 60 to 100 percent bonus. Large-cap listed base is $650,000 to $1.1 million. Median total compensation was $4.76m for sitting general counsel who are named executive officers at 236 of the largest US-listed companies in the 2026 proxy season (Sartori & Partners analysis of SEC proxy filings). That total is context. A nonprofit health system cannot be bid off it. The fee is 25-30 percent of total first-year compensation. A retainer of 30 percent of the fee is paid at engagement. Full bands: general counsel salary 2026.

Do you run healthcare GC searches on retained terms only?

Yes. GC, CLO and CCO searches run retained, with the fee fixed in writing before outreach. The fee is 25-30 percent of total first-year compensation. A retainer of 30 percent of the fee is paid at engagement. The replacement window is 12 months. We never approach lawyers we placed for as long as they stay, and we do not recruit from a client's legal department for 24 months after a mandate. Offer acceptance on corporate mandates is 96 percent. Retained corporate mandates complete at 92 percent. Fee, replacement window and off-limits are in the letter before we call anyone.

Which markets do you run healthcare GC searches in?

Corporate mandates have run in 23 countries and 41 cities since 2017. The statutes on this page are United States federal law. The published file in this orbit is a NASDAQ-listed medtech succession in Boston. Companies hiring in that market can also start at in-house counsel recruiting in Boston. The sector pages are hospitals and health systems, managed care and payers and digital health.

Healthcare legal officer

Brief the healthcare GC search against the four files, not a generic corporate description.

Retained. Fee, replacement window and off-limits in the letter before we call anyone. No obligation.